Henry Skinner, PhD, MBE, MJur

Henry Skinner, PhD, MBE, MJur, is the CEO of the AMR Action Fund, a mission-driven fund financing the development of urgently needed antimicrobials. He earned a PhD in Microbiology and an MS in Biochemistry from the University of Illinois, an MS in Bioethics from Harvard Medical School, an MJur in Health Law, Policy, and Management from Texas A&M, and an MS and BS in Biology/Biotechnology from Worcester Polytechnic Institute.